pMKO.1 puro p53 shRNA 1 Citations (10)
Originally described in: Telomerase maintains telomere structure in normal human cells.Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB, Brooks MW, Kaneko S, Murakami S, DeCaprio JA, Weinberg RA, Stewart SA, Hahn WC Cell. 2003 Jul 25. 114(2):241-53. PubMed Journal
Articles Citing pMKO.1 puro p53 shRNA 1
Articles |
---|
Reprogramming of embryonic human fibroblasts into fetal hematopoietic progenitors by fusion with human fetal liver CD34+ cells. Sandler VM, Lailler N, Bouhassira EE. PLoS One. 2011 Apr 14;6(4):e18265. doi: 10.1371/journal.pone.0018265. PubMed |
Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas. Karst AM, Levanon K, Duraisamy S, Liu JF, Hirsch MS, Hecht JL, Drapkin R. Gynecol Oncol. 2011 Oct;123(1):5-12. doi: 10.1016/j.ygyno.2011.05.021. Epub 2011 Jun 17. PubMed |
Primary culture and immortalization of human fallopian tube secretory epithelial cells. Karst AM, Drapkin R. Nat Protoc. 2012 Sep;7(9):1755-64. doi: 10.1038/nprot.2012.097. Epub 2012 Aug 30. PubMed |
beta-Asarone induces senescence in colorectal cancer cells by inducing lamin B1 expression. Liu L, Wang J, Shi L, Zhang W, Du X, Wang Z, Zhang Y. Phytomedicine. 2013 Apr 15;20(6):512-20. doi: 10.1016/j.phymed.2012.12.008. Epub 2013 Jan 26. PubMed |
15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-gamma, SMAD2/3, and TAP63 proteins. Lu D, Han C, Wu T. J Biol Chem. 2013 Jul 5;288(27):19484-502. doi: 10.1074/jbc.M113.453886. Epub 2013 May 16. PubMed |
Plumbagin suppresses tumor cell growth in oral squamous cell carcinoma cell lines. Ono T, Ota A, Ito K, Nakaoka T, Karnan S, Konishi H, Furuhashi A, Hayashi T, Yamada Y, Hosokawa Y, Kazaoka Y. Oral Dis. 2015 May;21(4):501-11. doi: 10.1111/odi.12310. Epub 2015 Jan 29. PubMed |
Delta40p53 suppresses tumor cell proliferation and induces cellular senescence in hepatocellular carcinoma cells. Ota A, Nakao H, Sawada Y, Karnan S, Wahiduzzaman M, Inoue T, Kobayashi Y, Yamamoto T, Ishii N, Ohashi T, Nakade Y, Sato K, Itoh K, Konishi H, Hosokawa Y, Yoneda M. J Cell Sci. 2016 Dec 15. pii: jcs.190736. PubMed |
Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53. Arena G, Cisse MY, Pyrdziak S, Chatre L, Riscal R, Fuentes M, Arnold JJ, Kastner M, Gayte L, Bertrand-Gaday C, Nay K, Angebault-Prouteau C, Murray K, Chabi B, Koechlin-Ramonatxo C, Orsetti B, Vincent C, Casas F, Marine JC, Etienne-Manneville S, Bernex F, Lombes A, Cameron CE, Dubouchaud H, Ricchetti M, Linares LK, Le Cam L. Mol Cell. 2018 Feb 15;69(4):594-609.e8. doi: 10.1016/j.molcel.2018.01.023. PubMed |
Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response. Lin S, Yu L, Song X, Bi J, Jiang L, Wang Y, He M, Xiao Q, Sun M, Olopade OI, Zhao L, Wei M. Cell Death Dis. 2019 Sep 11;10(9):666. doi: 10.1038/s41419-019-1871-z. PubMed |
p53 regulates katanin-p60 promoter in HCT 116 cells. Kirimtay K, Selcuk E, Kelle D, Erman B, Karabay A. Gene. 2020 Feb 15;727:144241. doi: 10.1016/j.gene.2019.144241. Epub 2019 Nov 9. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.